广济药业取得甲钴胺片药品注册证书

Core Viewpoint - Guangji Pharmaceutical (000952.SZ) has received the drug registration certificate for Mecobalamin tablets from the National Medical Products Administration, marking a significant advancement in the company's product portfolio for the treatment of peripheral nerve diseases [1] Group 1 - The approval of the Mecobalamin tablet registration certificate indicates important progress in the company's product layout in the field of peripheral nerve disease treatment [1] - This development provides domestic patients with a high-quality domestic drug option [1]